LMT503 First-in-human SAD, MAD, and FE Study
LMT503 First-in-human SAD, MAD, and FE Study
Not yet recruiting · NCT05659953 · Registry updated 2026-09-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| LMT503 First-in-human SAD, MAD, and FE Study | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 1 | 2026-09-01 | NCT05659953 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lmito Therapeutics Inc. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| ICON plc Company - Early Development Services | Groningen | Netherlands | 1 |